- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04209101
Medical Students and Psychoactive Substances Use (NC)
Medical Students and Psychoactive Substances Use: For Whom to Worry?
Medical students are heavy users of psychoactive substances, and even if levels of use vary depending on the universities, the average levels are higher than most other students.
In France, however, the use of licit or illicit substance has not been precisely described in medical students. The aim of this study was therefore to define the different modes of consumption of medical students.
Methods: This study was a cross-sectional survey in medical students from the University of Montpellier, and the investigators performed a cluster analysis of data. Both medical students and residents were included. Socio-demographic, medico-psychological and addictological data were collected.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Montpellier, France, 34295
- Uhmontpellier
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria:
- students had to be aged 18
- to be medical students
Exclusion criteria:
- refusal
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Define the different modes of consumption
Time Frame: 1 day
|
The aim of this study was therefore to define the different modes of consumption of medical students.
|
1 day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hélène Donnadieu-Rigole, MD PhD, University Hospital, Montpellier
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RECHMPL19_0615
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychoactive Substances Consumption
-
Finnish Institute for Health and WelfareEuropean Commission; Hospital District of Helsinki and UusimaaUnknownPrevalence of Psychoactive Substances in Road Traffic | Psychoactive Substances in Accident Involved Drivers | Relative Risk Estimation of Accident Involvement for Impaired DriversFinland
-
Assistance Publique - Hôpitaux de ParisMission Interministérielle de Lutte contre les Drogues et les Conduites Addictives... and other collaboratorsCompletedPsychoactive Substances Consumption | Substance-related Disorder | Off Label-use | Cognitive EnhancementFrance
-
University Hospital, BordeauxRegional Health Agency New AquitaineCompletedPoisoning by Psychoactive SubstancesFrance
-
Hospices Civils de LyonCompletedPsychoactive Substances ConsumersFrance
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Catalan Society of Family Medicine; Unitat de Suport a la Recerca, Barcelona...UnknownChronic Disease | Traffic Accident | Prevalence of Psychoactive Substances in Road Traffic | Relative Risk Estimation of Accident for Impaired DriversSpain
-
Oslo University HospitalSt. Olavs Hospital; Lovisenberg Diakonale Hospital; Oslo MunicipalityRecruitingAlcohol Consumption | Psychoactive Substance UseNorway
-
Shijiazhuang Yiling Pharmaceutical Co. LtdCompletedMetabolism of Radioactive SubstancesChina
-
Hitit UniversityCompletedEffects of Banned SubstancesTurkey
-
K. LiebCompletedCognitively Healthy Subjects Influenced by Psychoactive DrugsGermany
-
Bnai Zion Medical CenterCompletedContaminated Medical or Biological SubstancesIsrael